InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Nardo Christopher J., SVP, Développement. Officer active across 1 companies, notably Dermata Therapeutics, Inc.. In total, 2 reports have been published. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
2,439 shares
Common Stock
SEC:0000905718-21-001096·
2,439 shares
Common Stock
SEC:0000905718-21-001096:0·
2 of 2 declarations
About Nardo Christopher J.
Christopher J. Nardo is the Senior Vice President of Development at Dermata Therapeutics, Inc. In this role, he is responsible for leading product development initiatives and research and development strategy. With a strong background in the pharmaceutical sector, he plays a key role in advancing the company's projects and innovating treatments.
